
|Videos|July 23, 2013
Episode 5 - Current Therapeutic Strategies for Hemophilia
Advertisement
Systemic lupus erythematosus (SLE) is a complex autoimmune process with the potential to detrimentally impact every organ system in the human body. According to Dr. Michelle Petri, up to two-thirds of SLE cases are due to genetic predisposition, with SLE being more prevalent and severe among African- and Hispanic-Americans. The remaining one-third of cases may be attributed to environmental and hormonal components, with women being affected more than men in a 9:1 ratio. The implications of SLE are far-reaching, and it is important to develop a greater understanding of the disease to further improve current diagnostic and management strategies.
Advertisement
Related to this article

Panelists concurred that precision medicine can serve to exacerbate care inequality if not everyone can access these therapeutics.

Employer diabetes guide; Camden psychedelic therapy input; CRC after EMR; rural HFrEF care; JAMA obesity report.

This article analyzes gaps in US biosimilar development, quantifies market opportunities, and proposes policy and economic solutions to improve cost savings and patient access.

An employer coalition's new guide outlines how workplaces can prevent and manage diabetes, from benefit design to accommodations.

New York hepatitis B experts say screening gaps and weekly monitoring demands could limit who benefits from the first functional cure therapy.

San Francisco experts say earlier IgA nephropathy and FSGS detection depends on primary care education and care coordinators.

Earlier MASH fibrosis detection is more urgent now that treatments exist, and automating FIB-4 in EHRs could help primary care, says Rohit Loomba, MD.
Advertisement
Advertisement



















